Compounds > mci 9038
Page last updated: 2024-08-26

mci 9038 and MODS

mci 9038 has been researched along with MODS in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ernst, NE; Gallagher, EM; Keegan, SP; Mueller, EW; Young, EJ1
Huber, W; Moessmer, G; Phillip, V; Saugel, B; Schmid, RM1
Behr, J; Beiras-Fernandez, A; Dolch, ME; Frey, L; Hatz, R; Irlbeck, M; Lung Transplant Group, TM; Uberfuhr, PA1
Beiderlinden, M; Görlinger, K; Peters, J; Treschan, TA1
Bellmann, R; Dunzendorfer, S; Joannidis, M; Pechlaner, C; Schusterschitz, N; Stein, M1
Higashiyama, M; Kambayashi, J; Mori, T; Sakon, M; Tanaka, T; Tsujinaka, T; Yokota, M1

Trials

1 trial(s) available for mci 9038 and MODS

ArticleYear
Argatroban anticoagulation in critically ill patients.
    The Annals of pharmacotherapy, 2007, Volume: 41, Issue:5

    Topics: Anticoagulants; Arginine; Critical Illness; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Multiple Organ Failure; Partial Thromboplastin Time; Pipecolic Acids; Sulfonamides; Thrombocytopenia

2007

Other Studies

5 other study(ies) available for mci 9038 and MODS

ArticleYear
Effects of critical illness and organ failure on therapeutic argatroban dosage requirements in patients with suspected or confirmed heparin-induced thrombocytopenia.
    The Annals of pharmacotherapy, 2009, Volume: 43, Issue:1

    Topics: Adult; Aged; Anticoagulants; Arginine; Cohort Studies; Critical Illness; Dose-Response Relationship, Drug; Female; Heparin; Humans; Male; Middle Aged; Multiple Organ Failure; Pipecolic Acids; Retrospective Studies; Sulfonamides; Thrombocytopenia

2009
Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study.
    Critical care (London, England), 2010, Volume: 14, Issue:3

    Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Arginine; Critical Care; Dose-Response Relationship, Drug; Female; Heparin; Humans; Intensive Care Units; Male; Middle Aged; Multiple Organ Failure; Pipecolic Acids; Retrospective Studies; Sulfonamides; Survival Analysis; Thrombocytopenia

2010
Extracorporeal membrane oxygenation bridging to lung transplant complicated by heparin-induced thrombocytopenia.
    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2010, Volume: 8, Issue:4

    Topics: Adult; Anticoagulants; Arginine; Extracorporeal Membrane Oxygenation; Fatal Outcome; Heparin; Humans; Lung Transplantation; Male; Multiple Organ Failure; Pipecolic Acids; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Sulfonamides; Thrombocytopenia; Time Factors; Treatment Outcome

2010
Influence of continuous veno-venous hemofiltration on argatroban clearance in a patient with septic shock.
    Intensive care medicine, 2008, Volume: 34, Issue:7

    Topics: Anticoagulants; Arginine; Fatal Outcome; Female; Hemofiltration; Heparin; Humans; Middle Aged; Multiple Organ Failure; Pipecolic Acids; Shock, Septic; Sulfonamides; Thrombocytopenia

2008
The effect of heparin on multiple organ failure and disseminated intravascular coagulation in a sepsis model.
    Thrombosis research, 1990, Nov-15, Volume: 60, Issue:4

    Topics: Animals; Antithrombins; Arginine; Blood Coagulation; Disease Models, Animal; Disseminated Intravascular Coagulation; Heparin; Infections; Male; Multiple Organ Failure; Pipecolic Acids; Rabbits; Sulfonamides

1990